These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
7. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
8. Ovarian carcinoma: the role of chemotherapy. Thigpen JT; Vance RB; Lambuth BW Semin Oncol; 1988 Jun; 15(3 Suppl 3):16-23. PubMed ID: 3293214 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
11. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date. Harper P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217 [TBL] [Abstract][Full Text] [Related]
13. The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience. Thigpen T; Vance RB; McGuire WP; Hoskins WJ; Brady M Semin Oncol; 1995 Dec; 22(6 Suppl 14):23-31. PubMed ID: 8553080 [TBL] [Abstract][Full Text] [Related]
14. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers. Muggia FM Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530 [TBL] [Abstract][Full Text] [Related]
17. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
19. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix. Thigpen T; Vance R; Khansur T; Malamud F Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451 [TBL] [Abstract][Full Text] [Related]
20. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Thigpen T; Vance RB; Khansur T Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]